The Veteran's cholinergic urticaria is rated at 30 percent, effective from August 15, 2011. The Board found that the Veteran's symptoms more closely approximated a need for intermittent systemic immunosuppressive therapy to control his symptoms.
The deciding factor: The Veteran's symptoms were not constant and did not require continuous immunosuppressive therapy despite being prescribed multiple antihistamines and Omalizumab (Xolair).
- Claimed conditions
- Cholinergic Urticaria
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- April 17, 2018
- Citation
- 1823314
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 1823314.
What this means for you
A grant means the Board allowed the benefit or issue identified in this decision. Review the original order: other issues in the same appeal may have a different outcome, and this decision does not predict another claim.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Partly granted
The Veteran was granted an initial rating of 60 percent for cholinergic urticaria prior to January 15, 2016. The appeal is denied for a rating in excess of 10 percent beginning January 15, 2016.,The Veteran's TDIU claim was granted for the entire period prior to January 15, 2016.
- Denied
The Veteran's service-connected cholinergic urticaria is rated at 10 percent, and the Board found no evidence of more than this level of disability.
- Granted
The Board granted an earlier effective date of May 29, 1981 for the increased rating for cholinergic urticaria and a December 31, 1983 for TDIU. The Veteran is currently in receipt of a 60% rating for cholinergic urticaria with an effective date of August 11, 1993.
- Granted
The Veteran's cholinergic urticaria was granted an initial 10 percent rating effective May 28, 2011. The condition is manifested by recurrent episodes of rash occurring at least four times during a previous 12-month period that responds to treatment with antihistamines.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.